Robotic GI & Bariatric Surgery Specialist — Max Hospital Dwarka, Delhi
+91 7042373880
Book Appointment

Procedures > Metabolic Surgery

Metabolic Surgery for Diabetes in Delhi

Surgical treatment for Type 2 diabetes, metabolic syndrome, and obesity-related conditions — achieving remission where medications have failed.

80%
Diabetes Remission
after metabolic surgery
2000+
Metabolic Surgeries
performed by Dr. Wadhawan
98%
Success Rate
at Max Hospital, Dwarka
Procedures

Metabolic Surgery Procedures

These procedures work through hormonal and anatomical changes that go far beyond simple calorie restriction, producing durable metabolic improvements.

DJB

Duodenal-Jejunal Bypass (DJB)

DJB excludes the duodenum and proximal jejunum from food passage, dramatically altering gut hormone secretion. This produces rapid improvement in insulin sensitivity and glucose control, often within days of surgery — before significant weight loss occurs. Particularly effective for lean or mildly overweight patients with T2DM.

T2DM Treatment BMI 25+
SADI-S

SADI-S (Single Anastomosis Duodeno-Ileal Bypass with Sleeve)

SADI-S combines a sleeve gastrectomy with a single anastomosis duodeno-ileal bypass, creating both restriction and significant malabsorption. It achieves some of the highest weight-loss outcomes (80–90% EWL) while treating Type 2 diabetes with up to 90% remission rates. Suitable for super-obese patients with metabolic comorbidities.

High BMI Maximum Weight Loss
MGB

Metabolic Gastric Bypass

The mini gastric bypass (MGB) performed with metabolic intent for patients with Type 2 diabetes and moderate BMI (27.5–35). The procedure reshapes gut anatomy to maximise GLP-1 secretion and improve insulin sensitivity. It achieves 80% T2DM remission with 60–70% excess weight loss and is performed robotically for precision and safety.

T2DM + Weight BMI 27.5+
MSS

Metabolic Syndrome Surgery

For patients with the full metabolic syndrome — diabetes, hypertension, dyslipidaemia, and central obesity — surgical intervention produces dramatic and durable improvements across all parameters. Procedure selection is tailored to BMI, dominant comorbidity, and patient preference, and may include sleeve gastrectomy, bypass, or metabolic-specific procedures.

Full Syndrome Tailored Plan
Eligibility

Who Qualifies for Metabolic Surgery?

Metabolic surgery eligibility is broader than traditional bariatric criteria. Dr. Wadhawan follows IDF and DSI guidelines for Asian patients.

BMI < 35 kg/m² with uncontrolled Type 2 diabetes (HbA1c > 8%) despite optimal medical therapy
BMI 27.5–35 kg/m² with Type 2 diabetes and at least one other metabolic comorbidity (hypertension, dyslipidaemia, NAFLD)
Type 2 diabetes patients who have failed multiple medication regimens including insulin
Patients with metabolic syndrome defined as central obesity + 2 of: raised triglycerides, low HDL, hypertension, raised fasting glucose
Age 18–65 years with acceptable anaesthetic risk (individual assessment for those outside this range)
Willingness and capacity for lifelong dietary modification and nutritional supplementation post-surgery

Note: These are general guidelines. Every case is assessed individually by Dr. Wadhawan. Patients not meeting standard criteria may still be considered based on severity of disease and response to medical management.

FAQ

Metabolic Surgery FAQs

Metabolic surgery and bariatric surgery often use the same operations, but they differ in primary intent. Bariatric surgery targets weight loss. Metabolic surgery targets metabolic diseases — primarily Type 2 diabetes — and may be offered to patients with BMI as low as 27.5 kg/m² where traditional bariatric thresholds would not apply.
Up to 80% of patients with Type 2 diabetes achieve complete remission after metabolic surgery — meaning normal blood glucose without medication. An additional 15% experience significant improvement requiring fewer medications. The earlier in the diabetes course that surgery is performed, the higher the remission rate.
Blood sugar improvements often begin within 24–48 hours of surgery — before significant weight loss has occurred. This confirms the hormonal mechanism of action. Most patients can reduce or stop diabetes medications within days to weeks of surgery, under medical supervision.
Using Asian-specific guidelines, metabolic surgery may be considered for patients with BMI as low as 27.5 kg/m² if they have uncontrolled Type 2 diabetes and at least one other metabolic risk factor. Dr. Wadhawan follows IDF (International Diabetes Federation) and DSI (Diabetes Surgery Summit) guidelines.
Studies with 10+ year follow-up show durable metabolic benefits in the majority of patients. Even patients who experience some weight regain often maintain improved metabolic profiles compared to medical management alone. Ongoing dietary adherence and follow-up are key to sustaining results.
Diabetic patients may have higher baseline cardiovascular risk and slower wound healing. Our pre-operative programme optimises blood sugar control, nutritional status, and cardiac risk before surgery. Robotic minimally invasive technique further reduces wound complications in this patient group.

Consult Delhi's Best Robotic Surgeon

Schedule a consultation with Dr. Randeep Wadhawan at Max Hospital, Dwarka, New Delhi.

Book Consultation Call Now